202 related articles for article (PubMed ID: 25938799)
1. Kinetic Differences and Synergistic Antiviral Effects Between Type I and Type III Interferon Signaling Indicate Pathway Independence.
Voigt EA; Yin J
J Interferon Cytokine Res; 2015 Sep; 35(9):734-47. PubMed ID: 25938799
[TBL] [Abstract][Full Text] [Related]
2. De novo assembly and transcriptome analysis of Atlantic salmon macrophage/dendritic-like TO cells following type I IFN treatment and Salmonid alphavirus subtype-3 infection.
Xu C; Evensen Ø; Munang'andu HM
BMC Genomics; 2015 Feb; 16(1):96. PubMed ID: 25765343
[TBL] [Abstract][Full Text] [Related]
3. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
[TBL] [Abstract][Full Text] [Related]
4. Pseudorabies virus-induced expression and antiviral activity of type I or type III interferon depend on the type of infected epithelial cell.
Yin Y; Ma J; Van Waesberghe C; Devriendt B; Favoreel HW
Front Immunol; 2022; 13():1016982. PubMed ID: 36405751
[TBL] [Abstract][Full Text] [Related]
5. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.
Pervolaraki K; Stanifer ML; Münchau S; Renn LA; Albrecht D; Kurzhals S; Senís E; Grimm D; Schröder-Braunstein J; Rabin RL; Boulant S
Front Immunol; 2017; 8():459. PubMed ID: 28484457
[TBL] [Abstract][Full Text] [Related]
6. Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses.
Tan H; Derrick J; Hong J; Sanda C; Grosse WM; Edenberg HJ; Taylor M; Seiwert S; Blatt LM
J Interferon Cytokine Res; 2005 Oct; 25(10):632-49. PubMed ID: 16241862
[TBL] [Abstract][Full Text] [Related]
7. Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance.
Pervolaraki K; Rastgou Talemi S; Albrecht D; Bormann F; Bamford C; Mendoza JL; Garcia KC; McLauchlan J; Höfer T; Stanifer ML; Boulant S
PLoS Pathog; 2018 Nov; 14(11):e1007420. PubMed ID: 30485383
[TBL] [Abstract][Full Text] [Related]
8. Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces.
Stanifer ML; Guo C; Doldan P; Boulant S
Front Immunol; 2020; 11():608645. PubMed ID: 33362795
[TBL] [Abstract][Full Text] [Related]
9. The unique regulation and functions of type III interferons in antiviral immunity.
Odendall C; Kagan JC
Curr Opin Virol; 2015 Jun; 12():47-52. PubMed ID: 25771505
[TBL] [Abstract][Full Text] [Related]
10. Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription.
Choudhary S; Gao J; Leaman DW; De BP
J Virol; 2001 May; 75(10):4823-31. PubMed ID: 11312354
[TBL] [Abstract][Full Text] [Related]
11. Differential gene induction by type I and type II interferons and their combination.
Sanda C; Weitzel P; Tsukahara T; Schaley J; Edenberg HJ; Stephens MA; McClintick JN; Blatt LM; Li L; Brodsky L; Taylor MW
J Interferon Cytokine Res; 2006 Jul; 26(7):462-72. PubMed ID: 16800785
[TBL] [Abstract][Full Text] [Related]
12. Fish virus-induced interferon exerts antiviral function through Stat1 pathway.
Yu FF; Zhang YB; Liu TK; Liu Y; Sun F; Jiang J; Gui JF
Mol Immunol; 2010 Aug; 47(14):2330-41. PubMed ID: 20627394
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of type III interferon expression.
Iversen MB; Paludan SR
J Interferon Cytokine Res; 2010 Aug; 30(8):573-8. PubMed ID: 20645874
[TBL] [Abstract][Full Text] [Related]
14. Type I interferons are essential mediators of apoptotic death in virally infected cells.
Tanaka N; Sato M; Lamphier MS; Nozawa H; Oda E; Noguchi S; Schreiber RD; Tsujimoto Y; Taniguchi T
Genes Cells; 1998 Jan; 3(1):29-37. PubMed ID: 9581980
[TBL] [Abstract][Full Text] [Related]
15. Shared and Distinct Functions of Type I and Type III Interferons.
Lazear HM; Schoggins JW; Diamond MS
Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506
[TBL] [Abstract][Full Text] [Related]
16. Interferon-lambda: a new addition to an old family.
Donnelly RP; Kotenko SV
J Interferon Cytokine Res; 2010 Aug; 30(8):555-64. PubMed ID: 20712453
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of virus inhibition by consensus interferon YM643.
Yasuda S; Huffman JH; Smee DF; Sidwell RW; Miyata K
Antivir Chem Chemother; 2000 Sep; 11(5):337-41. PubMed ID: 11142632
[TBL] [Abstract][Full Text] [Related]
18. Type I and III interferon production in response to RNA viruses.
Reid E; Charleston B
J Interferon Cytokine Res; 2014 Sep; 34(9):649-58. PubMed ID: 24956361
[TBL] [Abstract][Full Text] [Related]
19. Induction and regulation of IFNs during viral infections.
Malmgaard L
J Interferon Cytokine Res; 2004 Aug; 24(8):439-54. PubMed ID: 15320958
[TBL] [Abstract][Full Text] [Related]
20. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
Zaritsky LA; Bedsaul JR; Zoon KC
J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
